EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study

Marta Pascual-Mato iD, Gabriel Gárate iD, Vicente González-Quintanilla, Jorge Madera-Fernández, Beatriz Castro, María José García, Javier Crespo iD, Montserrat Rivero, Julio Pascual iD

Headache: The Journal of Head and Face Pain · 2024-07 · 64 (7) · 849-858

DOI: 10.1111/head.14768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 24.06.2024. Verfasst von Marta Pascual-Mato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqué…. Hauptthemen laut MEDLINE: Migraine Disorders, Inflammatory Bowel Diseases, Comorbidity, Calcitonin Gene-Related Peptide. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the specificity of calcitonin gene–related peptide (CGRP) levels, we measured alpha‐CGRP circulating levels in a large series of patients with a recent diagnosis of inflammatory bowel disease (IBD) who were interviewed regarding comorbid headache.

Background

Several studies have found an association between migraine and IBD.

Methods

In this cross‐sectional study performed in an IBD clinic, morning serum alpha‐CGRP levels were measured by enzyme‐linked immunosorbent assay in 96 patients who were recently diagnosed with IBD and compared to those from 50 similar patients with chronic migraine (CM) and 50 healthy controls (HC).

Results

Alpha‐CGRP levels were higher in patients with IBD (median [interquartile range] 56.9 [35.6–73.9] pg/mL) and patients with CM (53.0 [36.7–73.9] pg/mL) compared to HC (37.2 [30.0–51.8] pg/mL; p = 0.003; p = 0.019, respectively). Regarding IBD diagnostic subtypes, alpha‐CGRP levels for ulcerative colitis (67.2 ± 49.3 pg/mL; 57.0 [35.6–73.4] pg/mL) and Crohn's disease (54.9 ± 27.5 pg/mL; 57.7 [29.1–76.1] pg/mL) were significantly higher than those of HC ( p = 0.013, p = 0.040, respectively). Alpha‐CGRP levels were further different in patients with IBD with migraine (70.9 [51.8–88.7] pg/mL) compared to HC ( p < 0.001), patients with IBD without headache (57.5 [33.3–73.8] pg/mL; p = 0.049), and patients with IBD with tension‐type headache but without migraine (41.7 [28.5–66.9] pg/mL; p = 0.004), though alpha‐CGRP levels in patients with IBD without migraine (53.7 [32.9–73.5] pg/mL) remained different over HC ( p = 0.028).

Conclusion

Together with CM, circulating alpha‐CGRP levels are different in patients with IBD, perhaps reflecting a chronic inflammatory state. IBD is an example of how alpha‐CGRP levels are not a totally specific migraine biomarker. However, alpha‐CGRP levels were further increased in patients with IBD who have a history of migraine, which reinforces its role as a biomarker in migraine patients, always bearing in mind their comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersInflammatory Bowel DiseasesComorbidityCalcitonin Gene-Related PeptideHumansCross-Sectional StudiesFemaleMaleAdultMiddle AgedEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

Crohn's diseasealpha‐calcitonin gene–related peptidecalcitonin gene–related peptidechronic migraineinflammatory bowel diseaseulcerative colitis

Substanzen

Calcitonin Gene-Related Peptide

Autor:innen und Institutionen

  • Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain.
  • Service of Neurology, University Hospital Marqués de Valdecilla, Universidad de Cantabria and IDIVAL, Santander, Spain.

ORCID-Profile: Marta Pascual-Mato, Gabriel Gárate, Javier Crespo, Julio Pascual

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Pascual-Mato, M., Gárate, G., González-Quintanilla, V., Madera-Fernández, J., Castro, B., García, M. J., Crespo, J., Rivero, M., & Pascual, J. (2024). Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study. Headache: The Journal of Head and Face Pain, 64(7), 849-858. https://doi.org/10.1111/head.14768

Vancouver

Pascual-Mato M, Gárate G, González-Quintanilla V, Madera-Fernández J, Castro B, García MJ, et al. Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study. Headache: The Journal of Head and Face Pain. 2024;64(7):849-858. doi:10.1111/head.14768

BibTeX
@article{PascualMato2024,
  author = {Pascual-Mato, Marta and Gárate, Gabriel and González-Quintanilla, Vicente and Madera-Fernández, Jorge and Castro, Beatriz and García, María José and Crespo, Javier and Rivero, Montserrat and Pascual, Julio},
  title = {Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  volume = {64},
  number = {7},
  pages = {849--858},
  doi = {10.1111/head.14768}
}
Kostenlos starten →